Regulators of homologous recombination repair as novel targets for cancer treatment

Por Krajewska, Małgorzata, Fehrmann, Rudolf S. N., de Vries, Elisabeth G. E., van Vugt, Marcel A. T. M.
Publicado no Front Genet (2015)

ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1

Por Renes, Johan, de Vries, Elisabeth G E, Nienhuis, Edith F, Jansen, Peter L M, Müller, Michael
Publicado em 1999

The analysis of longitudinal quality of life measures with informative drop-out: a pattern mixture approach

Por Post, Wendy J., Buijs, Ciska, Stolk, Ronald P., de Vries, Elisabeth G. E., le Cessie, Saskia
Publicado em 2009

Human stromal cells are required for an anti-breast cancer effect of zoledronic acid

Por Nienhuis, Hilde H., Arjaans, Marlous, Timmer-Bosscha, Hetty, de Vries, Elisabeth G.E., Schröder, Carolina P.
Publicado no Oncotarget (2015)

Growth Differentiation Factor 15 (GDF-15) Plasma Levels Increase during Bleomycin- and Cisplatin-Based Treatment of Testicular Cancer Patients and Relate to Endothelial Damage

Por Altena, Renske, Fehrmann, Rudolf S. N., Boer, Hink, de Vries, Elisabeth G. E., Meijer, Coby, Gietema, Jourik A.
Publicado no PLoS One (2015)

Automated mass spectrometric analysis of urinary and plasma serotonin

Por de Jong, Wilhelmina H. A., Wilkens, Marianne H. L. I., de Vries, Elisabeth G. E., Kema, Ido P.
Publicado em 2010

Inhibition of IGF-1R-Dependent PI3K Activation Sensitizes Colon Cancer Cells Specifically to DR5-Mediated Apoptosis But Not to rhTRAIL

Por Pennarun, Bodvael, Kleibeuker, Jan H., Oenema, Tjitske, Stegehuis, Janet H., de Vries, Elisabeth G.E., de Jong, Steven
Publicado no Anal Cell Pathol (Amst) (2010)

VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside

Por Arjaans, Marlous, Schröder, Carolina P., Oosting, Sjoukje F., Dafni, Urania, Kleibeuker, Josée E., de Vries, Elisabeth G.E.
Publicado no Oncotarget (2016)

Functional Genomic mRNA Profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor types

Por Lamberts, Laetitia E., de Groot, Derk Jan A., Bense, Rico D., de Vries, Elisabeth G.E., Fehrmann, Rudolf S.N.
Publicado no Oncotarget (2015)

Objective allergy markers and risk of cancer mortality and hospitalization in a large population-based cohort

Por Taghizadeh, Niloofar, Vonk, Judith M., Hospers, Jeannette J., Postma, Dirkje S., de Vries, Elisabeth G. E., Schouten, Jan P., Boezen, H. Marike
Publicado no Cancer Causes Control (2014)

Translating Pharmacogenomics: Challenges on the Road to the Clinic

Por Swen, Jesse J, Huizinga, Tom W, Gelderblom, Hans, de Vries, Elisabeth G. E, Assendelft, Willem J. J, Kirchheiner, Julia, Guchelaar, Henk-Jan
Publicado em 2007

Fas Ligand Expression in Lynch Syndrome-Associated Colorectal Tumours

Por Koornstra, Jan J., de Jong, Steven, Boersma-van Eck, Wietske, Zwart, Nynke, Hollema, Harry, de Vries, Elisabeth G.E., Kleibeuker, Jan H.
Publicado em 2008

Everolimus Induces Rapid Plasma Glucose Normalization in Insulinoma Patients by Effects on Tumor As Well As Normal Tissues

Por Fiebrich, Helle-Brit, Siemerink, Ester J.M., Brouwers, Adrienne H., Links, Thera P., Remkes, Wouter S., Hospers, Geke A.P., de Vries, Elisabeth G. E.
Publicado em 2011

Positron emission tomography of tumour [(18)F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy

Por van Kruchten, Michel, Glaudemans, Andor W. J. M., de Vries, Erik F. J., Schröder, Carolien P., de Vries, Elisabeth G. E., Hospers, Geke A. P.
Publicado no Eur J Nucl Med Mol Imaging (2015)

Extracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer (89)Zr-imgatuzumab

Por Pool, Martin, Kol, Arjan, Lub-de Hooge, Marjolijn N., Gerdes, Christian A., de Jong, Steven, de Vries, Elisabeth G.E., Terwisscha van Scheltinga, Anton G.T.
Publicado no Oncotarget (2016)

Pro- and anti-apoptotic effects of p53 in cisplatin-treated human testicular cancer are cell context-dependent

Por di Pietro, Alessandra, Koster, Roelof, Boersma-van Eck, Wytske, Dam, Wendy A., Mulder, Nanno H., Gietema, Jourik A., de Vries, Elisabeth G.E., de Jong, Steven
Publicado em 2012

Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism

Por Maring, Jan Gerard, Wachters, Floris M., Slijfer, Monique, Maurer, J. Marina, Boezen, H. Marike, Uges, Donald R. A., de Vries, Elisabeth G. E., Groen, Harry J. M.
Publicado em 2010

Words Matter: Distinguishing “Personalized Medicine” and “Biologically Personalized Therapeutics”

Por Cherny, Nathan I., de Vries, Elisabeth G. E., Emanuel, Linda, Fallowfield, Lesley, Francis, Prudence A., Gabizon, Alberto, Piccart, Martine J., Sidransky, David, Soussan-Gutman, Lior, Tziraki, Chariklia
Publicado no J Natl Cancer Inst (2014)

Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors (pNET): Final Overall Survival (OS) Results of the RADIANT-3 Study

Por Pommier, Rodney, Pavel, Marianne, Lombard-Bohas, Catherine, Van Cutsem, Eric, Lam, Du, Kunz, Tiffany, Brandt, Ulrike, Capdevila, Jaume, De Vries, Elisabeth G.E., Tomassetti, Paola, Hobday, Timothy, Yao, James C.
Publicado no Gastrointest Cancer Res (2014)

New positron emission tomography tracer [(11)C]carvedilol reveals P-glycoprotein modulation kinetics

Por Bart, Joost, Dijkers, Eli C F, Wegman, Theodora D, de Vries, Elisabeth G E, van der Graaf, Winette T A, Groen, Harry J M, Vaalburg, Willem, Willemsen, Antoon T M, Hendrikse, N Harry
Publicado em 2005